Clinical Trial

G-POEM for Glycemic Control in Diabetic Gastroparesis

Study acronym: DIAPOEM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Gastroparesis, commonly caused by diabetes, affects 30-50% of diabetic individuals and complicates glycemic control due to its bidirectional relationship with blood glucose levels. Current treatments are often ineffective. G-POEM, a minimally invasive endoscopic technique, has demonstrated promising results in improving digestive symptoms, particularly in diabetic patients, with over 80% success. However, its impact on glycemic control has not yet been investigated, highlighting the need for further research.
Trial Details
NCT Number NCT06965543
Lead Sponsor French Society of Digestive Endoscopy
Conditions Gastroparesis
Enrollment 40 participants
Start Date 2025-07
Primary Completion 2027-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-11